Annotation Detail for SLC35C1

Basic Information
Top
Pathway ID | Pathway Name |
---|
| Transmembrane transport of small molecules |
Pathway ID | Pathway Name |
---|
500363 | Transport of nucleotide sugars |
Desease ID | Desease Name |
---|
H00099 | Leukocyte adhesion deficiency |
| Immune system diseases |
| Inherited disorders of glycan/glycoprotein metabolism |
| Primary immunodeficiency |
H00119 | Congenital disorders of glycosylation (CDG) type II |
| Genetic disorders |
Desease Name |
---|
Congenital disorder of glycosylation, type IIc |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SLC35C1 mRNA | affects expression | 17562736
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SLC35C1 mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SLC35C1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.23 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.41 | 19490988 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
6.10 | 17688650 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.71 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.94 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.86 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.86 | 20603192 18177632 19232924 17688650 19460635 18940202 18558336 18316065 18985861 17157402 15238991 18396377 18775368 17507914 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.26 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.66 | 8888407 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.41 | 3084413 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.81 | 10977129 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.83 | 20734317 |
OMIM:266265 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.91 | 16575769 8888407 17688650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
4.13 | 19420014 19739265 11421492 11529661 19923254 18071297 10774834 19416960 2444490 14725611 17562736 11739529 16109766 10915739 16393943 12705907 17522070 11743745 12392966 14986274 16081117 17906064 10663392 11461765 19164858 11834606 19085960 16227642 12958197 11287661 12153990 14550746 12594235 16781746 16177239 12540782 15619225 18713872 15968718 16485898 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.13 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.96 | 19426721 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.58 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.81 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.78 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.12 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
4.00 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.95 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.81 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.78 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.75 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.71 | 8888407 18558336 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.54 | 16983495 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.61 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
3.06 | 16870215 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.28 | 16612254 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.42 | 12587719 15629191 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.20 | 16294345 17596541 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.71 | 19784758 16611625 19460945 11587558 19014921 16610002 12969438 12587719 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.68 | 17185352 16871587 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
5.13 | 17228818 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.22 | 19513568 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.50 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.51 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.37 | 17596541 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.39 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.26 | 18514411 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.77 | 16870215 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.57 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.41 | 12752131 11422049 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.70 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.11 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
3.02 | 11044598 11738929 1511512 17978042 16876388 15475178 14763951 3137016 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.13 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.41 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
6.10 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.26 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.30 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.50 | 10982225 |
Pathway ID |
Pathway Name |
---|
REACT:15518 |
Transmembrane transport of small molecules |